06/06/2024 5:20 PM | Behbahani Ali (Reporting) Black Diamond Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/06/2024 4:50 PM | Black Diamond Therapeutics (Issuer) Dhingra Kapil (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/06/2024 4:52 PM | Black Diamond Therapeutics (Issuer) Campbell Shannon (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/06/2024 4:53 PM | Black Diamond Therapeutics (Issuer) Raman Prakash (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/06/2024 4:54 PM | Black Diamond Therapeutics (Issuer) Menzel Garry E (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/06/2024 4:55 PM | Black Diamond Therapeutics (Issuer) Kulkarni Samarth (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/13/2024 6:09 PM | Black Diamond Therapeutics (Subject) New Enterprise Associates 16, L.P. (Filed by)
| Form SC 13D/A | |
|
05/09/2024 7:48 PM | Black Diamond Therapeutics (Subject) RA CAPITAL MANAGEMENT, L.P. (Filed by)
| Form SC 13D/A | |
05/09/2024 6:10 AM | Black Diamond Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
05/09/2024 6:13 AM | Black Diamond Therapeutics (Filer)
| Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
04/24/2024 3:04 PM | Black Diamond Therapeutics (Filer)
| Form ARS | |
04/12/2024 4:28 PM | Black Diamond Therapeutics (Issuer) Raman Prakash (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
04/12/2024 4:29 PM | Black Diamond Therapeutics (Issuer) Campbell Shannon (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
04/12/2024 4:27 PM | Black Diamond Therapeutics (Issuer) Raman Prakash (Reporting)
| Form 3 Initial statement of beneficial ownership of securities | |
04/12/2024 4:27 PM | Black Diamond Therapeutics (Issuer) Campbell Shannon (Reporting)
| Form 3 Initial statement of beneficial ownership of securities | |
04/12/2024 3:48 PM | Black Diamond Therapeutics (Filer)
| Form PRE 14A | |
04/11/2024 7:03 AM | Black Diamond Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
04/03/2024 8:00 PM | Behbahani Ali (Reporting) Black Diamond Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
04/03/2024 7:49 PM | Black Diamond Therapeutics (Issuer) DIXON WENDY L (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/12/2024 7:01 AM | Black Diamond Therapeutics (Filer)
| Form S-8 Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
03/12/2024 6:17 AM | Black Diamond Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
03/12/2024 6:20 AM | Black Diamond Therapeutics (Filer)
| Form 10-K Annual report pursuant to Section 13 or 15(d) | |
03/11/2024 12:14 PM | Black Diamond Therapeutics (Subject) T. Rowe Price Investment Management, Inc. (Filed by)
| Form SC 13G/A | |
02/15/2024 4:45 PM | Black Diamond Therapeutics (Issuer) Ni Fang (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/15/2024 4:34 PM | Black Diamond Therapeutics (Issuer) Jones Erika (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/15/2024 4:35 PM | Black Diamond Therapeutics (Issuer) Velleca Mark A. (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/15/2024 4:36 PM | Black Diamond Therapeutics (Issuer) Buck Elizabeth (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/15/2024 4:37 PM | Black Diamond Therapeutics (Issuer) Yurasov Sergey (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/15/2024 4:38 PM | Black Diamond Therapeutics (Issuer) Hatzis-Schoch Brent (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/13/2024 5:05 AM | BB BIOTECH AG (Filed by) Black Diamond Therapeutics (Subject)
| Form SC 13G/A | |
01/04/2024 7:07 AM | Black Diamond Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
12/15/2023 3:48 PM | Behbahani Ali (Reporting) Black Diamond Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
12/15/2023 3:40 PM | Black Diamond Therapeutics (Issuer) DIXON WENDY L (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
12/13/2023 6:08 AM | Black Diamond Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
11/09/2023 4:24 PM | Black Diamond Therapeutics (Subject) Versant Venture Capital VI, L.P. (Filed by)
| Form SC 13D/A | |
11/06/2023 6:14 AM | Black Diamond Therapeutics (Filer)
| Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
11/06/2023 6:10 AM | Black Diamond Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
10/19/2023 2:08 PM | BB BIOTECH AG (Reporting) BIOTECH GROWTH N V (Reporting) Black Diamond Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
09/18/2023 4:34 PM | Behbahani Ali (Reporting) Black Diamond Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
09/18/2023 4:25 PM | Black Diamond Therapeutics (Issuer) DIXON WENDY L (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
09/18/2023 4:26 PM | Black Diamond Therapeutics (Issuer) Velleca Mark A. (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
Write this ticker symbol down… (Ad) A megatrend now poised to mint a brand-new wave of millionaires right here in America.
And today, self-made millionaire Tim Bohen is giving you an inside look at the megatrend that’s going to change everything. Discover the #1 company leading this revolution |
09/18/2023 6:12 AM | Black Diamond Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
08/11/2023 6:26 AM | Black Diamond Therapeutics (Filer)
| Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
08/11/2023 6:22 AM | Black Diamond Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
07/07/2023 3:30 PM | Black Diamond Therapeutics (Issuer) Kolchinsky Peter (Reporting) RA Capital Healthcare Fund LP (Reporting) RA CAPITAL MANAGEMENT, L.P. (Reporting) RA Capital Nexus Fund, L.P. (Reporting) Shah Rajeev M. (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
07/06/2023 3:45 PM | Behbahani Ali (Reporting) Black Diamond Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
07/03/2023 2:36 PM | BB BIOTECH AG (Reporting) BIOTECH GROWTH N V (Reporting) Black Diamond Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/29/2023 12:37 PM | BB BIOTECH AG (Reporting) BIOTECH GROWTH N V (Reporting) Black Diamond Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/29/2023 5:02 AM | Black Diamond Therapeutics (Filer)
| Form 424B5 | |
06/27/2023 2:52 PM | Black Diamond Therapeutics (Subject) Epstein David M. (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
06/27/2023 6:11 AM | Black Diamond Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
06/16/2023 5:42 PM | Behbahani Ali (Reporting) Black Diamond Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/16/2023 4:41 PM | Black Diamond Therapeutics (Issuer) Velleca Mark A. (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/16/2023 4:41 PM | Black Diamond Therapeutics (Issuer) DIXON WENDY L (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |